Comparative effectiveness of ustekinumab versus infliximab in the management of perianal fistulizing Crohn's disease: a retrospective study in China
UST may serve as a promising alternative to IFX for the treatment of perianal fistulizing CD.
Authors
- Tong Tu (ORCID: https://orcid.org/0009-0008-3461-9692)
- Mengqi Chen (ORCID: https://orcid.org/0000-0001-9728-8511)
- Jianming Lin
- Xiaojun Zhuang
- Minhu Chen (ORCID: https://orcid.org/0000-0001-8181-0846)
- Zhirong Zeng
- Zihan Chen (ORCID: https://orcid.org/0009-0007-2522-6654)
- Xiaoling Li (ORCID: https://orcid.org/0009-0007-8561-5758)
- Yao He (ORCID: https://orcid.org/0000-0003-1549-6849)
- Linxin Liu (ORCID: https://orcid.org/0009-0001-2276-6600)
- Baili Chen (ORCID: https://orcid.org/0000-0003-1755-5806)
Institutions
- Sun Yat-sen University (CN)
- Buchang Pharma (China) (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
Publication Details
- Journal
- Intestinal Research
- Published
- 2025-06-11
- DOI
- https://doi.org/10.5217/ir.2024.00168
- Citations
- 1
- Primary Topic
- Diverticular Disease and Complications
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- National Natural Science Foundation of China